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ABSTRACT
Dendritic-cell-specific intercellular adhesion molecule-3-
grabbing non-integrin (DC-SIGN; CD209) has an impor-
tant role in mediating adherence of Mycobacteria spe-
cies, including M. tuberculosis and M. bovis BCG to
human dendritic cells and macrophages, in which these
bacteria can survive intracellularly. DC-SIGN is a C-type
lectin, and interactions with mycobacterial cells are
believed to occur via mannosylated structures on the
mycobacterial surface. Recent studies suggest more
varied modes of binding to multiple mycobacterial
ligands. Here we identify, by affinity chromatography
and mass-spectrometry, four novel ligands of M. bovis
BCG that bind to DC-SIGN. The novel ligands are
chaperone protein DnaK, 60 kDa chaperonin-1 (Cpn60.1),
glyceraldehyde-3 phosphate dehydrogenase (GAPDH)
and lipoprotein lprG. Other published work strongly
suggests that these are on the cell surface. Of these
ligands, lprG appears to bind DC-SIGN via typical protein-
glycan interactions, but DnaK and Cpn60.1 binding do
not show evidence of carbohydrate-dependent interac-
tions. LprG was also identified as a ligand for DC-SIGNR
(L-SIGN; CD299) and the M. tuberculosis orthologue of
lprG has been found previously to interact with human
toll-like receptor 2. Collectively, these findings offer
new targets for combating mycobacterial adhesion
and within-host survival, and reinforce the role of DC-
SIGN as an important host ligand in mycobacterial
infection.
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INTRODUCTION
Tuberculosis is the world’s most prevalent infectious disease
affecting a third of the global human population. The
causative agent of tuberculosis, Mycobacterium tuberculosis,
avoids the destructive capacity of the host immune system by
residing inside the phagosome of host mononuclear phago-
cytes (Armstrong and Hart, 1975; Clemens and Horwitz,
1995; Sturgill-Koszycki et al., 1996). Many studies have
shown that M. tuberculosis,M. paratuberculosis andM. bovis
BCG can bind to dendritic-cell-specific intercellular adhesion
molecule-3-grabbing non-integrin (DC-SIGN/CD209) to pro-
mote entry into human dendritic cells (DCs) and alveolar
macrophages (Geijtenbeek et al., 2003; Maeda et al., 2003;
Tailleux et al., 2003; Pitarque et al., 2005; Appelmelk et al.,
2008). A recent study indicates that a mutation of DC-SIGN
causing lower expression is protective against tuberculosis-
induced lung cavitation (Vannberg et al., 2008). DC-SIGN is a
44 kDa type II transmembrane protein that consists of a
carbohydrate recognition domain, neck domain, transmem-
brane domain and cytoplasmic tail. It is expressed mainly on
DCs and on selected macrophage populations including
alveolar macrophages (Geijtenbeek et al., 2000a; Lee et al.,
2001; Maeda et al., 2003). DC-SIGN is a calcium-dependent
lectin and has a high affinity for mannosylated surfaces,
forming tetrameric complexes when binding to high mannose
glycoproteins, such as HIV gp120 (Geijtenbeek et al., 2000b;
Feinberg et al., 2001; Mitchell et al., 2001; Appelmelk et al.,
2003). DC-SIGN has been shown to bind lipolysaccharide Lex
and mannose structures found on bacteria, such as Helico-
bacter pylori, Klebsiella pneumonia and M. tuberculosis
(Appelmelk et al., 2003; Geijtenbeek et al., 2003; Tailleux et
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al., 2003; van Kooyk and Geijtenbeek, 2003). Using purified
cell wall components from mycobacteria, DC-SIGN was
shown to bind lipoarabinomannan (LAM) structures from M.
tuberculosis, M. bovis andM. bovis BCG, all of which express
mannose-capped LAM (ManLAM). However, LAM purified
from M. smegmatis did not bind DC-SIGN, since it expresses
uncapped LAM, so-called AraLAM. Similarly, LAM from M.
avium bound poorly to DC-SIGN since it expresses single
mannose residue attachments and thus presents lower
mannoside density (Geijtenbeek et al., 2003; Maeda et al.,
2003). ManLAM was therefore believed to be the major ligand
on M. tuberculosis for binding to DC-SIGN (Maeda et al.,
2003; Tailleux et al., 2003). However, later studies showed
that removal of the mannose-cap in experiments using whole
bacteria did not appear to have a dramatic effect on DC-SIGN
binding. The faster growing mycobacteria such as M.
smegmatis or M. avium could also bind DC-SIGN despite
not having the mannose caps, suggesting that other
components in the mycobacterial cell wall were also binding
DC-SIGN. Mannosylated lipoproteins found on the cell
surface of mycobacteria such as 19 kDa lipoprotein
lpqH/Rv3763 and a 45 kDa lipoprotein were shown to
contribute to the binding of DC-SIGN to the bacteria (Pitarque
et al., 2005; Appelmelk et al., 2008). These studies have
revealed that the binding interaction of DC-SIGN to M.
tuberculosis is more complicated than originally perceived,
and suggests that there may be more potential DC-SIGN
ligands present on M. tuberculosis.
In this study we set out to demonstrate DC-SIGN binding to
M. bovis BCG as a model organism for M. tuberculosis. We
explored the binding characteristics of DC-SIGN to whole M.
bovis BCG and also observed the binding characteristics of a
closely related protein, DC-SIGNR (DC-SIGN-Related/L-
SIGN/CD299) to the mycobacterium. DC-SIGNR shares
77% amino acid sequence identity with DC-SIGN (Soilleux
et al., 2000). Using affinity chromatography, we purified and
identified four novel DC-SIGN binding ligands of M. bovis
BCG: chaperone protein DnaK (DnaK), 60 kDa chaperonin-1
(Cpn60.1), glyceraldehyde-3 phosphate dehydrogenase
(GAPDH) and lipoprotein lprG.
RESULTS AND DISCUSSION
We set out first to confirm the binding of DC-SIGN to wholeM.
bovis BCG, using lung surfactant protein A (SP-A) and BSA
as positive and negative controls respectively. We also
compared the binding of DC-SIGN to that of DC-SIGNR. By
flow cytometry, we found that the binding of DC-SIGN and
DC-SIGNR to whole M. bovis BCG is dose-dependent
(Fig. 1), reaching a maximum at a protein input of about
10 μg per 5 × 108 cells (Fig. 2A). SP-A also binds dose-
dependently, while BSA does not bind. Binding of DC-SIGN
and DC-SIGNR are predominantly Ca2+-dependent, as
binding is reduced by ~80% in the presence of EDTA
(Fig. 2B) compared with binding in 5 mM CaCl2. Binding of
SP-A appears less dependent on Ca2+ ions, as binding is
reduced < 50% in EDTA. Mannose (50 mM) inhibits the
binding of DC-SIGN and SP-A by less than 20%, while
binding of DC-SIGNR is reduced by about 70% (Fig. 2B).
These findings are compatible with the view that DC-SIGN,
DC-SIGNR and SP-A are all likely to be binding to several
bacterial ligands and the results with mannose and EDTA
suggest more than one mode of binding. For DC-SIGNR, the
results are consistent with its binding mainly (~80%) via its
calcium-dependent carbohydrate binding site. For DC-SIGN
and SP-A, a much smaller proportion (10%–20%) of binding
may be mediated via these sites, and other binding occurs via
Ca2+-independent sites, and also via Ca2+ dependent sites
that do not constitute the canonical carbohydrate binding site.
Similar diversity for modes of binding of SP-A to viable and
apoptotic mammalian cells has been observed previously
(Jäkel et al., 2010a, b, c).
To identify macromolecules on the mycobacterial cell
surface to which DC-SIGN is binding, M. bovis BCG lysates
were passed through a DC-SIGN affinity chromatography
column. Bound proteins were eluted with buffer containing
EDTA. The eluted proteins were then concentrated and
resolved by SDS-PAGE. From the gel (Fig. 3) four visible
bands can be seen at 74, 60, 37 and 27 kDa. As a control M.
bovis BCG lysates were passed through a control column
made of underivatised Sepharose in the same way. No
protein was detected in the eluted fractions of the control
column, indicating no non-specific binding interactions (not
shown). The 74, 60, 37 and 27 kDa bands were cut from the
gel and analyzed by MALDI-TOF tryptic peptide fingerprinting
mass spectrometry, and database searches carried out
against both NCIBr and SwissProt. The bands were identified
as chaperone protein DnaK, 60 kDa chaperonin (Cpn60.1),
glyceraldehyde-3-phosphate dehydrogenase (GADPH) and
lipoprotein lprG, respectively (Table 1). All of these have the
same protein sequence inM. tuberculosis as inM. bovis BCG
(Table 1). Two other minor candidates, CTP synthase and
ATP synthase beta subunit (Table 1) were not considered
further.
DnaK and Cpn60.1 are collectively known as heat shock
proteins or chaperone proteins. Cpn60.1 generated the
highest protein score, with nine peptide sequences matched.
These peptide sequences cover 38.51% of the protein
sequence (Table 1). The protein ran at ~60 kDa on a SDS-
PAGE gel and was calculated to have a mass of 55,877 Da
from the amino acid sequence (Fig. 3 and Table 1). The
second highest protein score was for DnaK. This protein band
produced four matching peptides sequences which contribute
11.2% sequence coverage. It ran at ~70 kDa on SDS-PAGE
and had a calculated mass from the amino acid sequence of
66,830 Da (Fig. 3 and Table 1).
Toward the C-terminal of Cpn60.1, there is one possible N-
linked glycosylation site at N506AS (Fig. 4). This potential
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N-linked glycosylation site occurs in one of the Cpn60.1
peptides identified during mass spectrometry. This indicates
that the site was not occupied by an oligosaccharide
otherwise the peptide molecular mass would have been
affected and unidentifiable during analysis. The site may be
partially occupied indicating that there may be another
population of this protein with an N-linked glycan present at
N506. However, the form of this protein identified after capture
by the affinity column was not glycosylated at this position,
and it is therefore very unlikely that DC-SIGN binds to this
ligand via its Ca2+-dependent lectin activity. Similarly, no
potential N-linked glycosylation sites for DnaK were found
(Fig. 4), suggesting that it also is not bound to DC-SIGN via N-
glycans. From the current literature it is unknown whether
these proteins undergo any O-linked glycosylation, but use of
in silico O-glycosylation prediction tools available at the
EXPASy (Expert Protein Analysis System) proteomics server
(http://expasy.org/tools/; Gasteiger et al., 2003) indicates no
predicted O-glycosylation in either protein.
A recent study (Hickey et al., 2009) showed that DnaK is
located at the cell-surface of M. tuberculosis. There are no
published data on the localization of Cpn60.1, but a related
protein, Cpn60.2 was also shown to be on the cell surface of
M. tuberculosis, and has a role in the adherence of M.
Figure 1. DC-SIGN, DC-SIGNR and SPA bind to whole M. bovis BCG. M. bovis BCG cells were washed in PBS and fixed in
paraformaldehyde. Bacteria alone (solid) or bacteria incubated with protein (open) (5 × 108 cells) were incubated with either
biotinylated-DC-SIGN, biotinyalted-DC-SIGNR, SP-A or biotinylated-BSA (1, 5, 10, 20 µg, respectively). SP-A binding was detected
by incubating the cells with a biotinylated monoclonal anti-SPA antibody. All cells were then treated with streptavidin-PE and binding
was measured using fluorescent cytometry. Biotinylated-BSA was used as a negative control. Results are representative of three
independent experiments.
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tuberculosis to macrophages (Hickey et al., 2009). Cpn60.1
and Cpn60.2 show 61% amino acid sequence identity (Kong
et al., 1993). Hickey et al. (2009) showed that macrophages
formed specific interactions with M. tuberculosis, which could
be inhibited by pre-incubation with increasing concentrations
of Cpn60.2 or by blocking surface localized Cpn60.2 with
F(ab’)2 antibody. This was supported by showing that purified
Cpn60.2 could bind to the surface of macrophages. Although
DnaK was also shown to be located at the mycobacterial cell-
surface, Hickey et al. (2009) could not show consistent
binding via DnaK to macrophages using antibodies to block
the reaction. This may have been due to a lack of appropriate
anti-DnaK antibodies. In Listeria monocytogenes, DnaK has
been shown to facilitate phagocytosis of the pathogen into
macrophages (Hanawa et al., 1999). The same authors
observed that wild type bacteria were endocytosed more than
DnaK knockouts. Once inside the macrophage DnaK was
shown not to be essential for multiplication within the cell
although it was necessary for cell entry. Studies looking at the
pathogenic role of the DnaK and its co-chaperone DnaJ, in
Salmonella enterica serovar Typhimurium revealed that they
are both essential for internalising the bacteria within
epithelial cells and survival within macrophages (Takaya et
al., 2004).
Cpn60.1 and Cpn60.2 are potent immunomodulatory
proteins in the host. Cpn60.1 has been shown to be a more
potent activator of stimulatory proinflammatory cytokines
(Friedland et al., 1993; Lewthwaite et al., 2001; Hu et al.,
2008). Despite chaperones being more commonly known as
cytosolic proteins, many pathogenic bacteria express these
proteins at the cell-surface possibly to promote attachment to
host cells and mediate internalization. Cpn60 proteins have
been reported to demonstrate these functions in Helicobacter
pylori, Clostridium difficile, Hemophilus ducreyi and Salmo-
nella enterica serovar Typhimurium (Yamaguchi et al., 1996;
Frisk et al., 1998; Hennequin et al., 2001). Here we
demonstrate that Cpn60.1 can also interact with DC-SIGN
and propose that this could aid the entry of mycobacterial
cells into DC or macrophage.
GAPDH was also identified as one of four DC-SIGN
binding ligands in this study. Running at ~37 kDa on SDS-
PAGE (Fig. 3), GAPDH was identified with three peptide
matches, covering 15.04% of the protein sequence. The
calculated mass of the protein is 35,955 Da and two potential
N-linked glycosylation sites are present in the sequence,
N53ST and N154AS (Table 1, Fig. 4). These two potential N-
linked glycosylation sites may be occupied by carbohydrate
structures required for DC-SIGN binding via its CRD. This
protein has significant homology to the GAPDH enzymes
indentified in Group A Streptococcus, enteropathogenic E.
coli, and Candida albicans (Parker and Bermudez, 2000).
GAPDH is an important enzyme in both prokaryotic and
eukaryotic metabolism that catalyzes a step of glycolysis,
converting glyceraldehyde-3-phosphate to glycerate
1,3-bisphosphate. GAPDH is more commonly recognized
as a cytosolic enzyme found on the inner surface of the cell
membrane. Even though there is no apparent signal
sequence or stretch of hydrophobic residues to indicate a
transmembrane region (Fig. 4), studies have reported that a
37 kDa protein homologous to GAPDH is expressed on the
Figure 2. Binding of DC-SIGN, DC-SIGNR and SPA to wholeM. bovis BCG.M. bovis BCG cells were washed in PBS and fixed
in paraformaldehyde. (A) 5 × 108 cells were incubated with 1, 5, 10, 20 µg biotinylated-DC-SIGN, biotinylated-DC-SIGNR, SP-A and
biotinylated-BSA in the presence of 5 mM CaCl2. After incubations, SP-A was detected using a biotinylated monoclonal anti-SP-A
antibody. Cells were then incubated with streptavidin-PE and binding was measured by flow cytometry. MFI (FL2-H) indicates the
mean fluorescent intensity of PE-positive cells. Results are expressed as the mean of three independent experiments ± SD. (B)
5 × 108 cells were incubated with 20 µg biotinylated-DC-SIGN, biotinylated-DC-SIGNR, SP-A and biotinylated BSA in the presence of
50mM mannose plus 5mM CaCl2, or 5 mM EDTA or 5 mM CaCl2 without mannose. Biotinylated-BSA was used as a negative
control. Cells were treated as above. Results are expressed as the mean of two independent experiments ± SD.
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outer cell membrane of hematopoietic cells (Allen et al., 1987)
and also on many microorganisms such as Group A
Streptococcus, enteropathogenic E. coli, Candida albicans,
Mycobacterium avium and Schistosoma mansoni (Goudot-
Crozel et al., 1989; Pancholi and Fischetti, 1992; Kenny and
Finlay, 1995; Gil-Navarro et al., 1997; Parker and Bermudez,
2000). M. avium expresses GAPDH on its cell surface,
whereupon GAPDH can bind to human epidermal growth
factor. In the presence of recombinant human epidermal
growth factor the rate of growth of M. tuberculosis and M.
avium is rapidly increased (Parker and Bermudez, 2000).
Another DC-SIGN ligand purified by affinity chromatogra-
phy was identified as lprG, a 24 kDa lipoprotein. LprG actually
runs with an apparent molecular weight of 27 kDa on SDS-
PAGE (Fig. 3) and was identified with only one peptide hit with
a protein score of 70.07, covering 7.62% of the protein
sequence. The calculated mass of the protein is 24,547 Da
(Fig. 4). The identification of lprG was supported by Western
blot analysis. As shown in Fig. 5, in eluted fractions DE1–2,
DE3–4 and DE5–6 from DC-SIGN affinity chromatography, a
strong band can be seen representing lprG. LprG has two
potential N-linked glycosylation sites, one of which (N83PT) is
unoccupied or only partially occupied since it lies in one of the
peptides identified by mass spectrometry. The other site,
N185AT may be occupied. Ligand blot analysis (Fig. 6) of
whole M. bovis BCG lysate incubated with either 125I-DC-
SIGN or 125I-DC-SIGNR revealed that DC-SIGN and DC-
SIGNR both bind the same protein at around 27 kDa, which
corresponds to lprG in our SDS-PAGE system, and is the only
ligand detected by this method. DC-SIGN and DC-SIGNR
binding to lprG can therefore still occur when the mycobacter-
ial protein has been denatured by SDS-PAGE. This strongly
suggests that lprG binds to DCSIGN predominantly or entirely
via protein-carbohydrate interactions.
In other studies looking at the importance of lprG in M.
tuberculosis, knockout of the lprG operon was shown to
attenuate M. tuberculosis, indicating that it has a prominent
role in the pathogenic behavior of the bacterium (Bigi et al.,
2004). Furthermore, lprG has been identified as a ligand for
TLR-2 on macrophages, and lprG-TLR-2 interactions lead to
reduced MHC class II presentation (Gehring et al., 2004).
There is also growing evidence indicating that intracellular
signaling via DC-SIGN modifies transduction pathways
downstream from TLRs, driving immunosuppressive
responses (Gringhuis et al., 2007, 2009).
Several other M. tuberculosis lipoproteins that are either
glycosylated or presumed to be glycosylated also have been
identified as key antigens with immunomodulatory functions
(Herrmann et al., 2000). LpqH (19 kDa) was confirmed to
have seven O-linked glycosylation sites (Herrmann et al.,
2000). It has the same protein sequence inM. tuberculosis as
in M. bovis BCG and was previously identified as a ligand for
DC-SIGN (Pitarque et al., 2005) possibly binding via glycans.
We were unable accurately to detect lipoproteins below
Figure 3. M. bovis BCG lysate proteins binding to immobilised DC-SIGN. DC-SIGN Sepharose was incubated with M. bovis
BCG lysate in 10mM Hepes, 140mM NaCl, 5 mM CaCl2 pH 7.4. The Sepharose was placed in a column and washed and bound
proteins were eluted with 10mM Hepes, 140mM NaCl, 5 mM EDTA pH 7.4. Eluted fractions were concentrated with Strataclean
beads and prepared in reducing conditions for analysis by SDS-PAGE. Concentrated eluates were run on 4%–12% gradient gel. As a
negative control, underivatised Sepharose was incubated with the lysate in the same way (results not shown). LS, 2 µL of M. bovis
BCG lysate; RT, 2 µL lysate proteins not bound to the column (“run-through”); DE1–4, concentrated eluted fractions 1–4 from the DC-
SIGN column. Bands marked by black arrows were used for mass spectrometry analysis. Results are representative of three
independent experiments.
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20 kDa in the affinity chromatography experiment shown in
Fig. 3 due to limitations in the SDS-PAGE system used, but in
Fig. 6 (ligand blotting) no band in the position of lpqH is seen.
This suggests either that lprG is a much better ligand (more
abundant or higher affinity) or that lpqH does not bind via
glycans.
LprG binds to both DC-SIGN and DC-SIGNR. DC-SIGNR
is expressed in the liver, lymph nodes but has also been
described in the lung (Pöhlmann et al., 2001; Jeffers et al.,
2004). In humans, both DCs and alveolar macrophages
express DC-SIGN in the lungs. Although DC-SIGNR has a
different expression pattern from DC-SIGN, it has similar
binding properties to DC-SIGN (Bashirova et al., 2001;
Mitchell et al., 2001; Pöhlmann et al., 2001). While DC-
SIGN has been shown to mediate endocytosis and protein
trafficking as a recycling receptor and the release of bound
ligand at reduced pH, DC-SIGNR does not endocytose nor
demonstrate pH-sensitive ligand binding (Guo et al., 2004).
DC-SIGN has been implicated as an important receptor in
the establishment ofM. tuberculosis infection. Although many
DC-SIGN ligands have been identified at the cell-surface of
the mycobacterium, studies suggested that there were more
ligands present that had not yet been identified. Here, we
have shown DC-SIGN binds to whole M. bovis BCG in both
Ca2+-dependent and Ca2+-independent modes. We have
identified four novel ligands for DC-SIGN. Of these only one,
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lprG appears to bind predominantly via the glycan binding
site. LprG is also a ligand for DC-SIGNR. Dendritic cells
present in the lung migrate in order to prime T lymphocytes in
the lymph nodes. It is believed that M. tuberculosis resides
within the phagosome of the DC and exploits the migration
thereby circulating within the host undetected (Fenton and
Vermeulen, 1996; Henderson et al., 1997; Banchereau and
Steinman, 1998). The discovery of new DC-SIGN binding
ligands: DnaK, Cpn60.1, GAPDH and lprG, may help further
research into designing inhibitors to prevent interactions
between DC-SIGN andM. tuberculosiswith the aim of blocking
uptake and intracellular survival of mycobacterial cells.
Figure 4. Protein sequences of the identified eluted proteins. Protein sequences of the four identified proteins eluted from DC-
SIGN affinity chromatography. (A) Chaperone protein DnaK (DnaK), (B) chaperone protein 60 (Cpn60.1), (C) glyceraldehyde 3-
phosphate dehydrogenase (GADPH), and (D) lipoprotein lprG (lprG). In red, peptides identified by MS-MS, and in purple, potential N-
linked glycosylation sites. Sequences were obtained from databases as described in the text.
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MATERIALS AND METHODS
Mycobacterial cultures
Liquid cultures of Mycobacterium bovis BCG (Pasteur strain) were
grown as described previously (Carroll et al., 2009) in Middlebrook
7H9 liquid medium containing 0.2% (v/v) glycerol, 0.05% (v/v) Tween-
80, and 10% (v/v) albumin-dextrose-catalase (ADC, BD BBL
Prepared Culture Medium: Becton Dickinson, Oxford, UK). Fresh
cultures were inoculated from 1mL glycerol stock ofM. bovis BCG to
generate a 100mL culture. The ‘first passage’ was grown for four to
five days at 37°C in roller bottles at 2 rpm until the bacteria had
reached the exponential growth phase (OD600nm = 0.80−1.00). Only
the first passages of the strains were used for experimental work.
Preparation of cell lytates
M. bovis BCG cell cultures (200mL) were harvested at exponential
phase and cells were washed three times in 137mM NaCl, 2.6mM
KCl, 8.2mM Na2HPO4 and 1.5mM KH2PO4, pH 7.4 (PBS). Cells
were resuspended in 3 mL 10mM Tris, 140mM NaCl, 0.5% Triton
X-100, pH 7.5 in the presence of protease inhibitors (Protease
Inhibitor Cocktail, Roche Diagnostics, Mannheim Germany) and kept
on ice for 5 min. The cells were then ribolysed in ribolysing tubes
containing Lysing Matrix B (MPBiomedicals, Illkirch, France) for 45 s
at speed setting 6.5 in a ribolyser (FastPrep FP120). Lysate was
placed on ice for 5 min before being spun down. To reduce viscosity,
mycobacterial lysate was incubated with 10 μg/mL of RNase A
(R4642 Sigma Aldrich,Poole UK) for 30min at 37°C. Lysate buffer
was adjusted to 2.5mM CaCl2, 2.5 mM MgCl2 and incubated with
10 μg/mL DNase II (D4138, Sigma Aldrich) for 30min at 37°C. The
lysate was then stored at −20°C until needed.
Protein Preparations
Recombinant, tetrameric DC-SIGN and DC-SIGNR (complete extra-
cellular domains, lacking the transmembrane segment) were made
and purified as described previously (Mitchell et al., 2001). These
were used in either unmodified, biotinylated or radioiodinated form.
Biotinylation was performed using N-hydroxysuccinimide biotin
(Sigma-Aldrich, Poole, UK) at a molar ratio of 20:1 reagent : protein
at pH 8.4, 4°C for 60min. Radioiodination was done as a standard
iodogen-catalyzed reaction (Krarup et al., 2007) with 50 µg of protein
in PBS and 250 uCi of Na125I (GE Healthcare, UK, product IMS-30).
SP-A was purified from human alveolar proteinosis broncho-alveolar
lavage fluid as described by Jäkel et al. (2010a).
Flow cytometry
M. bovis BCG (5 × 108 cells) were fixed in 1.5% paraformaldehyde in
PBS, 2mM CaCl2. Cells were washed in 100 µL 10mM Hepes,
140mMNaCl, 5 mMCaCl2, pH 7.4 (assay buffer) and resuspended in
150 µL of the same buffer. Cells were incubated with 0, 5, 10, 20 µg of
biotinylated-DC-SIGN or biotinylated-DC-SIGNR for 1 h at room
temperature in assay buffer. Incubations were also carried out in the
presence of 50mM mannose and 5mM EDTA as potential inhibitors
Figure 5. Western blot confirmation of lprG binding to DC-SIGN-Sepharose. SDS-PAGE of concentrated eluted fractions
were transferred to a PVDF membrane and blocked. The membrane was incubated with rabbit anti-lprG antiserum, then washed
and incubated with goat anti-rabbit-horseradish peroxidase (HRP)-conjugated antibody. The membrane was washed and exposed
to Enhanced Chemiluminescence Western Blot Detection Reagents. The bands were visualized by exposing the membrane to X-
ray film for a few seconds. Results are representative of 2 independent experiments. LS, lysate; RT, run-through; DE1–6, eluted
fractions from the DC-SIGN column; GE1–6, eluted fractions from the guard (underivatised Sepharose) column.
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of binding to M. bovis BCG. Cells were washed and incubated with
1:200 dilution of Streptavidin-PE solution (554061 BD Pharmingen,
Oxford, UK) for 40min in 100 µL assay buffer and fixed in 180 µL of
1.5% paraformaldehyde in PBS, 2mMCaCl2. Binding to the cells was
measured by flow cytometry using a FACScan instrument (Becton
Dickinson Immunocytometry Systems, San Jose, CA, USA). Aquisi-
tion and processing of data from 10,000 cells per sample were carried
out with the CellQuest software (Becton Dickinson). Surfactant
protein-A (SP-A) was used as positive control (Downing et al.,
1995; Pasula et al., 1997; Weikert et al., 1997) and was detected
using a biotinylated anti-SP-A monoclonal antibody (AntibodyShop,
Gentofte, Denmark); biotinylated BSA was used as a negative control
for binding to M. bovis BCG.
DC-SIGN Sepharose
Soluble recombinant DC-SIGN extracellular domain protein (2mL,
1mg/mL) in 10mM Hepes, 140mM NaCl, 5 mM CaCl2, pH 7.5 was
incubated with 1 mL hydrated CNBr-activated Sepharose (GE
Healthcare, Chalfont St. Giles, UK) for 2 h at room temperature with
rotation. The resin was washed twice in 1M NaCl and then incubated
in 3mL 100mM ethanolamine, pH 8.8 for 2 h at room temperature
with rotation. The resin was washed twice in 1M NaCl and stored in
25mM Hepes, 150mM NaCl, 5 mM EDTA, pH 7.5. Fifteen percent of
the DC-SIGN supplied remained unbound, as assessed by measur-
ing protein OD280 in the supernatant after binding.
DC-SIGN affinity chromatography
Capacity of the DC-SIGN-Sepharose for capturing glycoprotein
ligand was confirmed using a test solution containing 100 µg of
yeast invertase (20% oligomannose bymass) loaded onto the column
in 1 mL of 10mM Hepes, 140 mM NaCl, 5 mM CaCl2 pH 7.4
(equilibration buffer) and eluted with 10mM Hepes, 140mM NaCl,
5 mM EDTA pH 7.4 (eluting buffer). Successful capture and elution of
ligand was visualized by SDS-PAGE. The DC-SIGN-Sepharose
column was regenerated with 20mM Hepes, 2 M NaCl, 10mM EDTA
pH 7.4 (regeneration buffer). The column was then equilibrated with
equilibration buffer. Lysate treated with RNase and DNase was
diluted with one volume of 20mM Hepes, 140mM NaCl, 7.5mM
CaCl2, pH 7.5 to obtain 5mL with a protein concentration of about
5mg/mL. As a control, a second column (1mL) was made from
underivatised Sepharose (guard column) and prepared in equilibra-
tion buffer. Lysate (5 mL) was added to the guard column and the
beads were stirred at intervals during an incubation period of 2 h at
4°C. The lysate was then run off and loaded onto the DC-SIGN
column. Beads were resuspended and incubated with the lysate as
above. Both columns were washed exhaustively with equilibration
buffer. Bound ligands were eluted with eluting buffer and 0.5mL
fractions collected. Eluted proteins were detected by reading OD280,
and positive fractions were pooled and the protein concentrated by
binding to 40 µL Strataclean beads (Stratagene, Cedar Creek, TX,
USA) per mL of eluted fraction. Beads were incubated with eluates on
a rotary stirrer for 2 h. Beads were spun down and prepared for
analysis by SDS-PAGE.
SDS-PAGE
SDS-PAGE was performed using the Invitrogen NuPAGE® system
(Invitrogen, Cambridge, UK). Samples were prepared as described
by Fairbanks et al. (1971). A total of 20 µL Strataclean beads per
concentrated fraction were prepared in reducing conditions for SDS-
PAGE and loaded per well.
Western blotting
SDS-PAGE was run with SeeBlue® Plus2 Prestained Standard
(Invitrogen) to facilitate band size estimation. Protein bands were
transferred to a polyvinylidene fluoride (PVDF) microporous mem-
brane (Millipore, Billerica, Massachusetts, USA) in 48mM Tris-HCl,
39mM glycine, 20% (v/v) methanol, pH 8.3 (transfer buffer) for 4 h
using a semi-dry blotter (Whatman International Ltd. Banbury, UK).
The membrane was blocked with PBS, 0.2% Tween-20, 1 mg/mL
BSA for 2 h. The membrane was washed with PBS, 0.2% Tween-20,
0.5mM EDTA (washing buffer) and incubated with 1:300 dilution of
rabbit anti-lprG antiserum (Bigi et al., 1997) in PBS, 1mg/mL BSA for
3 h at room temperature. The membrane was washed in washing
buffer and incubated with 1:10,000 dilution goat anti-rabbit-horse-
radish peroxidase-conjugated antibody (Sigma Aldrich, A0545) in
PBS, 1 mg/mL BSA for 1 h. The membrane was washed in washing
buffer and exposed to Enhanced Chemiluminescence Western Blot
Detection Reagents (GE Healthcare) for detection. Bands were
detected by exposing the membrane to X-ray film.
Ligand blotting
SDS-PAGE of reduced M. bovis BCG lysate was run and protein
bands were transferred to a PVDF microporous membrane and
blocked as above. The membrane was washed with 25mM Hepes,
Figure 6. Radiolabelled DC-SIGN and DC-SIGNR binding
toM. bovisBCG blot. SDS-PAGE ofM. bovis BCG lysate was
run and protein bandswere transferred to a PVDF membrane,
blocked and incubated with 15mL of 350,000 dpm/mL of either
125I-DC-SIGN or 125I-DC-SIGNR. The bands were then
visualized by exposing the membrane to X-ray film for 1 week.
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150mM NaCl, 5 mM CaCl2, 0.02% Tween-20 pH 7.4 and incubated
with 15mL of 350,000 dpm/mL of either 125I-DC-SIGN or 125I-DC-
SIGNR for 2 h at room temperature. The membrane was washed with
25mM Hepes, 150mM NaCl, 5 mM CaCl2, 0.02% Tween-20 pH 7.4
and bands were visualized by exposing the membrane to X-ray film in
a lightproof cassette for 1 week.
Mass spectrometry
Protein bands from SDS-PAGE gels were stained with either
SafeStain (Invitrogen) or Coomassie Blue R-250 stain (Fairbanks et
al., 1971) and destained in 10% (v/v) acetic acid, 10% (v/v) ethanol.
Individual bands were excised and subjected to MS-MS analysis.
Mass spectrometric analysis was carried out using a Q-TOF 1
(Micromass, Manchester, UK) coupled to a CapLC (Waters, Milford,
USA). In-gel trypsin digestion was carried out as described by
Shevchenko et al. (2006). Tryptic peptides were concentrated and
desalted on a 300 µm id/5mM C18 pre-column and resolved on a
75 µm id/25 cm C18 PepMap analytical column (LC packings, San
Francisco, CA, USA). Peptides were eluted to the mass spectrometer
using a 45min 5%–95% (v/v) acetonitrile gradient containing 0.1%
(v/v) formic acid at a flow rate of 200 nL/min. Spectra were acquired in
positive mode with a cone voltage of 40 V and a capillary voltage of
3300 V. The MS to MS/MS switching was controlled in an automatic
data-dependent fashion with a 1 s survey scan followed by three 1 s
MS/MS scans of the most intense ions. Precursor ions selected for
MS/MS were excluded from further fragmentation for 2 min. Spectra
were processed using ProteinLynx Global Server 2.1.5 and searched
against the SwissProt_55.6 and NCBInr_20080718 databases using
the MASCOTsearch engine (Matrix Science, London, UK). Database
searches were performed with the taxonomy restricted to Mycobac-
teria. Carbamidomethyl cysteine was set as a fixed modification and
oxidised methionine as a potential variable modification. Data was
searched allowing 0.1 Da error on all spectra and up to one missed
tryptic cleavage site.
ABBREVIATIONS
Cpn60.1, 60 kDa chaperonin-1; DC, dendritic cell; DC-SIGN/CD209,
dendritic-cell-specific intercellular adhesion molecule-3-grabbing
non-integrin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase
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